HIF-1 Alpha, VEGF and MMP-8 Levels in PICF of Smokers Versus Non Smokers
NCT ID: NCT05325918
Last Updated: 2022-04-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
14 participants
OBSERVATIONAL
2021-08-29
2022-01-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Smoking on Macrophage-related Chemokines Before and After Non-surgical Treatment of Initial Peri-implantitis
NCT06810401
Cathelicidin LL-37 Levels in the GCF and the Saliva of Smokers and Non-smokers With Stage III,IV Periodontitis
NCT04861493
The Effect of Smoking on Peri-implantitis
NCT06150066
Effect of Smoking on Periapical Healing After NSRCT
NCT05799937
The Role of Smoking and Gingival Crevicular Fluid Markers on Coronally Advanced Flap Outcomes
NCT03539939
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The peri-implant crevicular fluid was obtained using periopaper strips then analyzed using ELISA kits of these markers; HIF-1 Alpha, VEGF and MMP-8
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
CROSS_SECTIONAL
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Individuals with restored implants placed one year or more before study enrollment
* Both genders
* Age range 20-50 years old
Exclusion Criteria
* Lactating females
20 Years
50 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Future University in Egypt
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sarah Elkot
Lecturer of Oral Medicine, Periodontology and Diagnosis, Faculty of Oral and Dental Medicine, Future University in Egypt, Cairo, Egypt.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sarah M Elkot, Lecturer
Role: PRINCIPAL_INVESTIGATOR
Lecturer of Oral Medicine and Periodontology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Faculty of oral and dental medicine,FUE, Cairo,Egypt
Cairo, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
FUE13
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.